ELRs NNS I-NP I-KP 0,4
are VBP I-VP O 5,8
particularly RB I-VP O 9,21
attractive JJ I-NP O 22,32
for IN I-PP O 33,36
the DT I-NP O 37,40
synthesis NN I-NP I-KP 41,50
of IN I-PP I-KP 51,53
block NN I-NP I-KP 54,59
copolymers NNS I-NP I-KP 60,70
that IN I-PP O 71,75
into IN I-PP O 90,94
polymer JJ I-NP I-KP 95,102
nanostructures NNS I-NP I-KP 103,117
such JJ I-NP O 118,122
as IN I-PP O 123,125
micelles. NN I-NP I-KP 126,134

The DT I-NP O 136,139
first JJ I-NP O 140,145
work NN I-NP O 146,150
in IN I-PP O 151,153
this DT I-NP O 154,158
area NN I-NP O 159,163
involved VBD I-VP O 164,172
an DT I-NP O 173,175
copolymer NN I-NP I-KP 201,210
containing VBG I-VP O 211,221
VPGEG–(IPGAG)4 NNP I-NP I-KP 222,236
and CC O O 237,240
VPGFG–(IPGVG)4 NNP I-NP I-KP 241,255
as IN I-PP O 256,258
the DT I-NP O 259,262
hydrophilic NN I-NP I-KP 263,274
and CC O I-KP 275,278
hydrophobic JJ I-NP I-KP 279,290
blocks, NN I-NP I-KP 291,297
respectively RB O O 299,311
[49]. JJ I-NP O 312,316

The DT I-NP O 318,321
resulting VBG I-NP O 322,331
micelles NNS I-NP I-KP 332,340
were VBD I-VP O 341,345
studied VBN I-VP O 346,353
by IN I-PP O 354,356
dynamic JJ I-NP I-KP 357,364
light JJ I-NP I-KP 365,370
scattering VBG I-VP I-KP 371,381
(DLS) NN I-NP O 382,387
and CC O O 388,391
DSC NNP I-NP I-KP 392,395
was VBD I-VP O 396,399
used VBN I-VP O 400,404
to TO I-VP O 405,407
measure VB I-VP O 408,415
the DT I-NP O 416,419
enthalpy NN I-NP O 420,428
of IN I-PP O 429,431

A DT I-NP O 447,448
copolymer NN I-NP I-KP 459,468
was VBD I-VP O 469,472
subsequently RB I-VP O 473,485
synthesized VBN I-VP O 486,497
and CC I-VP O 498,501
the DT I-NP O 502,505
TEM NNP I-NP I-KP 506,509
images NNS I-NP I-KP 510,516
of IN I-PP O 517,519
this DT I-NP O 520,524
polymer NN I-NP I-KP 525,532
showed VBD I-VP O 533,539
that IN I-PP O 540,544
it PRP I-NP O 545,547
formed VBD I-VP O 548,554
spherical JJ I-NP I-KP 555,564
aggregates NNS I-NP I-KP 565,575
[50]. VBP I-VP O 576,580

Other JJ I-NP O 582,587
multivalent JJ I-NP I-KP 588,599
spherical JJ I-NP I-KP 600,609
micelles NNS I-NP I-KP 610,618
have VBP I-VP O 619,623
been VBN I-VP O 624,628
obtained VBN I-VP O 629,637
from IN I-PP O 638,642
linear JJ I-NP I-KP 643,649
AB NNP I-NP I-KP 663,665
copolymers NNS I-NP I-KP 675,685
in IN I-PP O 686,688
the DT I-NP O 689,692
temperature NN I-NP O 693,704
range NN I-NP O 705,710
37–42°C CD I-NP O 711,718
with IN I-PP O 719,723
the DT I-NP O 724,727
aim NN I-NP O 728,731
of IN I-PP O 732,734
targeting VBG I-VP I-KP 735,744
cancer NN I-NP I-KP 745,751
cells NNS I-NP I-KP 752,757
[51]. VBP I-VP O 758,762

Bidwell NNP I-NP O 764,771
et CC O O 772,774
al. NNS I-NP O 775,777
have VBP I-VP O 779,783
also RB I-VP O 784,788
exploited VBN I-VP O 789,798
the DT I-NP O 799,802
ELRs NNP I-NP I-KP 803,807
for IN I-PP O 808,811
its PRP$ I-NP O 812,815
ability NN I-NP O 816,823
to TO I-VP O 824,826
serve VB I-VP O 827,832
as IN I-PP O 833,835
macromolecular JJ I-NP I-KP 836,850
carriers NNS I-NP I-KP 851,859
for IN I-PP O 860,863
thermally RB I-NP I-KP 864,873
targeted VBN I-NP I-KP 874,882
delivery NN I-NP I-KP 883,891
of IN I-PP I-KP 892,894
drugs. NN I-NP I-KP 895,900

Attachment NN I-NP O 902,912
of IN I-PP O 913,915
doxorubicin NN I-NP I-KP 916,927
to TO I-VP O 928,930
system NN I-NP I-KP 941,947
showed VBD I-VP O 948,954
enhanced JJ I-NP O 955,963
cytotoxicity NN I-NP I-KP 964,976
in IN I-PP O 977,979
uterine JJ I-NP I-KP 980,987
sarcoma NN I-NP I-KP 988,995
cells NNS I-NP I-KP 996,1001
when WRB O O 1002,1006
aggregation NN I-NP I-KP 1007,1018
was VBD I-VP O 1019,1022
induced VBN I-VP O 1023,1030
with IN I-PP O 1031,1035
hyperthermia NN I-NP I-KP 1036,1048
[52]. NN I-NP O 1049,1053

